BioMimetic Therapeutics, Inc. Earnings Conference Call (Q2 2012) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Aug 2 Calls
Today's Calls
Call Details
BioMimetic Therapeutics, Inc. Earnings Conference Call (Q2 2012)
Scheduled to start Thu, Aug 2, 2012, 4:30 pm Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About BioMimetic Therapeutics Inc (NasdaqGS:BMTI)Other Calls 
BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The company’s orthopedic products include Augment Bone Graft for open fracture and fusion treatment; and Augment Injectable Bone Graft for closed fracture treatment and minimally invasive fracture/fusion treatment. Its products also comprise Augment C to treat cartilage repair; Augment RC for rotator cuff tendon to bone repair; Augment AT for the treatment of acute tendon injuries; and Augment CT for chronic tendon injuries, as well as TBD, which is under development for spine fusion. The company was formerly known as BioMimetic Pharmaceuticals, Inc. and changed its name to BioMimetic Therapeutics, Inc. in July 2005. BioMimetic Therapeutics, Inc. was founded in 1999 and is headquartered in Franklin, Tennessee.


More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings


Copyright © 2012 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2012 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.